Mel Schilling, the renowned expert from “Married at First Sight” Australia and UK, passed away on March 24, 2026, at the age of 54 due to complications from terminal colon cancer. Despite undergoing a challenging 16 rounds of chemotherapy, she continued to participate in filming until her health took a turn for the worse in recent weeks.

Her husband recounted her last moments, sharing that she managed to convey a heartfelt message to him and their daughter, Maddie, even as she struggled to speak. As of now, the family has not disclosed any funeral arrangements.

​

Mel Schilling Dies Aged 54: MAFS Star Loses Brave Battle with Colon Cancer

Schilling’s passing concludes a widely publicized battle with cancer that garnered considerable support. Initially diagnosed in December 2023 with a tumor the size of a lemon, she had surgery and was initially given the all-clear.

Unfortunately, the cancer returned and spread to her lungs and brain by early 2026. In March of that year, Schilling shared the somber news that medical options had been exhausted, admitting uncertainty about her remaining time.

How Mel Schilling’s Cancer Spread to Her Brain – The Heartbreaking Timeline

• December 2023: Schilling was diagnosed with a lemon-sized tumor in her colon, which was surgically removed, and she was initially declared cancer-free.

• 2024-2025: The cancer returned, leading her to undergo 16 rounds of chemotherapy and radiotherapy while still participating in the filming of “Married at First Sight” UK.

• February 2025: Announced remission briefly, but treatment continued.​

• Early March 2026: Cancer spreads to brain and lungs; terminal diagnosis confirmed.

• March 24, 2026: Passes away in London.

She shared updates openly, emphasizing her determination to fight until the end.

Who Was Mel Schilling? MAFS Dating Coach and Relationship Expert

Born in 1971 in Melbourne, Australia, Schilling was a psychologist and behavioral specialist before TV. She authored books on relationships and coached singles on communication and emotional patterns.

At 42, she became a mother to daughter Maddie (born November 3, 2015) and rose to fame on MAFS. She lived in London with husband Gareth Brisbane, whom she met online in 2010 and married in Bali in 2018.

Mel Schilling’s Iconic Role on Married at First Sight Australia and UK

Mel Schilling joined MAFS Australia in 2016 for season 2, serving 12 seasons as the direct yet empathetic expert. She later appeared on MAFS UK and Celebs Go Dating.

Known for tough-love advice on toxic dynamics, she helped shape the show’s success. In February 2026, she quit MAFS Australia to prioritize family and health in the UK.

Mel Schilling Cancer Diagnosis: The Lemon-Sized Tumour Found in 2023

A routine scan in late 2023 revealed the stage 3 colon cancer. Surgery removed the tumor, but recurrence followed despite aggressive treatment.

She filmed through chemo, crediting work with giving her purpose.

Mel Schilling’s Brave Fight: 16 Rounds of Chemotherapy While Filming MAFS

Schilling endured debilitating chemo but “never missed a day of filming,” her husband said. Symptoms like headaches and numbness emerged over Christmas 2025.

A clinical trial was planned, but the brain spread halted options.​

Mel Schilling Passes Away Peacefully Surrounded by Love – Husband’s Emotional Statement

Gareth Brisbane wrote: “Mel passed away peacefully today, surrounded by love.” He described her final whisper for their daughter as using “all her remaining strength.”

“Life is fleeting, fragile,” he added, urging fans to cherish loved ones.​

Reactions from Colleagues and Fans

Fellow MAFS expert John Aiken called her a “beautiful human being.” Tributes poured in from Channel 4, producers, and fans worldwide.

Her agent and friend Elizabeth Day were thanked for support. Social media filled with messages praising her impact on relationships.

What Happens Next?

No funeral plans announced. MAFS producers may adjust upcoming seasons; she had already left Australia version.

Her story could raise colon cancer awareness, as she urged early screenings.